The Antihypertensive Effects of a Pure and Selective Serotonin-Receptor Blocking Agent (R 41 468) in Elderly Patients

Abstract

In a first experiment, an acute intravenous administration of 10 mg R 41 468, a pure serotonin-receptor blocking agent with high selectivity for blood vessels and thrombocytes and devoid of central effects, dramatically reduced systolic and diastolic blood pressure in 23 elderly hypertensive patients. Heart rate and cardiac output remained virtually unchanged.

In a second double-blind placebo-controlled cross-over study a highly significant decrease of systolic and diastolic blood pressure was obtained in 14 elderly hypertensive patients during an 8-day oral treatment with 40 mg t.i.d. of R 41 468. No serious side-effects were observed. An oral maintenance therapy with R 41 468 for 3 weeks showed a further reduction of blood pressure, resulting in a normalization of blood pressure, taking into account the advanced age of the patients.

R 41 468 most probably acts by decreasing the venous capacitance bed constriction. Essential hypertension might be causally related to an impair ment of venous function, in which serotonin might be an important pressor factor.

Get full access to this article

View all access options for this article.

References

Rapport, M.M. , Green, A.A. , Page, I.H. : Crystalline serotonin. Science, 108: 329, 1948.

Woolley, D.W. , Shaw, E.N. : Antiserotonins in hypertension and the antimetabolite approach to chemotherapy. Science, 124: 34, 1956.

Woolley, D.W. , Shaw, E.N. : An antiserotonin which is active when fed . Pharmacology, 108: 87, 1953.

Ulrych, M. : Pathogenesis of essential hypertension. Role of the postcapillary segment of the circulation. Angiology, 30: 104,1979.

Greenberg, S. : Venous function in hypertension. TIPS, 1: 121, 1980.

Peroutka, S.J. , Snyder, S.H. : Multiple serotonin receptors: differential binding of [3H] 5-hydroxytryptamine, [3H] lysergic acid diethylamide and [3H] spiroperidol. Molecular Pharmacology, 16: 687, 1979.

Leysen, J.E. , Niemegeers, C.J.E. , Tollenaere, J.P. , Laduron, P.M. : Serotonergic component of neuroleptic receptors. Nature, 272: 168, 1978.

Leysen, J.E. , Awouters, F. , Kenis, L. , Laduron, P.M. , Vandenberk, J. , Janssen, P.A.J. : Receptor binding profile of seroquinaline, a novel antagonist at 5-HT2 receptors . Life sciences, submitted.

Janssen Pharmaceutica : R 41 468: The first pure and selective serotonin S2(5-HT2) receptor blocking agent. Investigational New Drug Brochure, Fourth Edition, June 1980.

10.

Davies, O.L. : Statistical Methods in Research and Production. London , Oliver and Boyd, 1947.

11.

Siegel, S. : Nonparametric Statistics. New York, McGraw-Hill Book Co., 1956, pp. 75-83.

12.

Magalini, S.I. , Stefanini, M. , Smith, F.E. : Vasopressor effect of synthetic 5-hydroxytryptamine creatinine sulfate in man. Proc. Soc. Exp. Biol. Med., 92: 433, 1956.

13.

Yokoyama, M. , Henry, P.D. : Supersensitivity of atherosclerotic arteries to ergonovine partially mediated by a serotonergic mechanism (abstract). Circulation 59, 60: (Suppl. II) II, 1979.

14.

Van Neuten, J.M. , Vanhoutte, P.M. : Selectivity of calcium-antagonism and serotonin-antagonism with respect to venous and arterial tissues. Angiology (in press)

15.

De Clerck F. , Janssen, P.A.J. : Human platelet aggregation by serotonin: inhibition by R 41468 in vitro and ex vivo. (Manuscript in preparation).